Article info

A randomised double blind trial versus placebo does not confirm the benefit of α-interferon in polyneuropathy associated with monoclonal IgM
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
  1. Professor Jean-Claude Brouet jc.brouet{at}chu-stlouis.fr
View Full Text

Citation

MARIETTE X, BROUET J, CHEVRET S, et al
A randomised double blind trial versus placebo does not confirm the benefit of α-interferon in polyneuropathy associated with monoclonal IgM

Publication history

  • First published August 1, 2000.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.